How Akura Medical wants to advance thrombectomy; What does da Vinci 5 mean for surgical robotics?
In this episode of DeviceTalks Weekly Co-Hosts Tom Salemi and Chris Newmarker pay a visit to the Wizard, Joe Mullings of The Mullings Group, to get his take on the disruptive force that is Intuitive’s da Vinci 5. What does this mean to the surgical robotics competitors both big and small?
Then Tom Salemi talks with Murali Srivathsa, CEO of Akura Medical, about the company’s aggressive moves to disrupt the thrombectomy. Akura is part of the prolific Shifamed accelerator, so we’ll talk about that innovative powerhouse as well as Srivathasa’s own career.
To register for the upcoming DeviceTalks Tuesday Surgical Robotics Week or DeviceTalks Boston go to DeviceTalks.com.
Thanks for listening to the DeviceTalks Podcast Network.
Subscribe now to the DeviceTalks Podcast Network on any major podcast player.
Then Tom Salemi talks with Murali Srivathsa, CEO of Akura Medical, about the company’s aggressive moves to disrupt the thrombectomy. Akura is part of the prolific Shifamed accelerator, so we’ll talk about that innovative powerhouse as well as Srivathasa’s own career.
To register for the upcoming DeviceTalks Tuesday Surgical Robotics Week or DeviceTalks Boston go to DeviceTalks.com.
Thanks for listening to the DeviceTalks Podcast Network.
Subscribe now to the DeviceTalks Podcast Network on any major podcast player.
Activity